Imidazopyridine derivatives as IL-17 modulators
US-12391688-B2 · Aug 19, 2025 · US
This page is not indexed by search engines while we improve data quality.
Reuberson James Thomas patents
Reuberson James Thomas is listed as an inventor on 36 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Reuberson James Thomas |
| Total patents | 36 |
| First publication | Jun 4, 2015 |
| Latest publication | Aug 19, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Imidazotriazine derivatives as il-17 modulators
US-2024294534-A1 · Sep 5, 2024 · US
Imidazopyridazine derivatives as il-17 modulators
US-2024140951-A1 · May 2, 2024 · US
Dicyclopropylmethyl derivatives as il-17 modulators
US-2023399328-A1 · Dec 14, 2023 · US
Difluorocyclohexyl derivatives as il-17 modulators
US-2023271951-A1 · Aug 31, 2023 · US
Fused imidazole derivatives as IL-17 modulators
US-11472794-B2 · Oct 18, 2022 · US
Fused Imidazole Derivatives as IL-17 Modulators
US-2022242855-A1 · Aug 4, 2022 · US
Imidazopyridine Derivatives as IL-17 Modulators
US-2022227764-A1 · Jul 21, 2022 · US
Therapeutically active pyrazolo-pyrimidine derivatives
US-RE48622-E · Jul 6, 2021 · US
Fused Imidazole Derivatives as IL-17 Modulators
US-2021053952-A1 · Feb 25, 2021 · US
Recent patents
Latest publications not already listed above.
Hexahydropyrazinotriazinone derivatives as kinase inhibitors
US-10450320-B2 · Oct 22, 2019 · US
Hexahydropyrazinotriazinone Derivatives as Kinase Inhibitors
US-2018362532-A1 · Dec 20, 2018 · US
Fused Pyrazole Derivatives As Kinase Inhibitors
US-2018298009-A1 · Oct 18, 2018 · US
Pyrazolo-pyridine derivatives as kinase inhibitors
US-10087180-B2 · Oct 2, 2018 · US
Fused Pyridine Derivatives As Kinase Inhibitors
US-2018273525-A1 · Sep 27, 2018 · US
Indazole Derivatives as Modulators of TNF Activity
US-2018222868-A1 · Aug 9, 2018 · US
Fused Bicyclic Heteroaromatic Derivatives as Kinase Inhibitors
US-2018201622-A1 · Jul 19, 2018 · US
Fused imidazole and pyrazole derivatives as modulators of TNF activity
US-10004737-B2 · Jun 26, 2018 · US
Fused bicyclic heteroaromatic derivatives as kinase inhibitors
US-10000497-B2 · Jun 19, 2018 · US
Fused bicyclic heteroaromatic derivatives as kinase inhibitors
US-9969748-B2 · May 15, 2018 · US
Fused bicyclic heteroaromatic derivatives as modulators of TNF activity
US-9815797-B2 · Nov 14, 2017 · US
Therapeutically active pyrazolo-pyrimidine derivatives
US-9714248-B2 · Jul 25, 2017 · US
Fused Bicyclic Heteroaromatic Derivatives as Kinase Inhibitors
US-2017129905-A1 · May 11, 2017 · US
Fused Imidazole and Pyrazole Derivatives as Modulators of TNF Activity
US-2017128445-A1 · May 11, 2017 · US
Pyrazolo-Pyridine Derivatives as Kinase Inhibitors
US-2017121324-A1 · May 4, 2017 · US
Fused Bicyclic Heteroaromatic Derivatives as Kinase Inhibitors
US-2017121337-A1 · May 4, 2017 · US
TNF -α modulating benzimidazoles
US-9550737-B2 · Jan 24, 2017 · US
Fused Bicyclic Heteroaromatic Derivatives As Modulators of TNF Activity
US-2016304470-A1 · Oct 20, 2016 · US
Therapeutically Active Pyrazolo-Pyrimidine Derivatives
US-2016194329-A1 · Jul 7, 2016 · US
Therapeutically active oxazoline derivatives
US-9382263-B2 · Jul 5, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Ucb Biopharma Sprl | 23 |
| Univ Leuven Kath | 19 |
| UCB Biopharma SRL | 10 |
| Ucb Pharma Sa | 4 |
| Brookings Daniel Christopher | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P29/00 | 35 |
| A61P35/00 | 27 |
| A61P37/06 | 25 |
| C07D487/04 | 20 |
| A61P37/00 | 16 |